Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04223791
Brief Title: Switch to Doravirine/Islatravir (DOR/ISL) in Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-018)

First Submitted : January 8, 2020
First Submitted that Met QC Criteria : January 8, 2020
First Posted : January 10, 2020

Last Update Submitted that Met QC Criteria : September 12, 2021
Last Update Posted : September 14, 2021